Table 6.
Primary endpoints by primary renal disease
| Membranous nephropathy | ||||
|---|---|---|---|---|
| Category | T1 (n = 93) | T2 (n = 47) | T3 (n = 45) | P |
| RRT (n = 27) | 13 (14%) | 10 (21%) | 4 (9%) | 0.236 |
| Death (n = 51) | 25 (27%) | 14 (30%) | 12 (27%) | 0.925 |
| Death or RRT (n = 69) | 32 (34%) | 21 (45%) | 16 (36%) | 0.476 |
| IgAN | ||||
| Category | T1 (n = 143) | T2 (n = 85) | T3 (n = 67) | P |
| RRT | 44 (31%) | 19 (22%) | 17 (25%) | 0.36 |
| Death | 37 (26%) | 14 (17%) | 6 (9%) | 0.011 |
| Death or RRT | 66 (46%) | 27 (32%) | 20 (30%) | 0.026 |
| FSGS | ||||
| Category | T1 (n = 78) | T2 (n = 57) | T3 (n = 57) | P |
| RRT | 16 (20.5%) | 10 (18.5%) | 7 (12.3%) | 0.448 |
| Death | 25 (32.1%) | 12 (22.2%) | 4 (7.0%) | 0.002 |
| Death or RRT | 31 (39.7%) | 19 (35.2%) | 11 (19.3%) | 0.037 |
T1–3, Tertiles 1–3; T1, most socio-economically deprived area. Estimate of significance using chi-square test. P < 0.05 = significant.